Game Creek Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Game Creek Capital's PFE Position: Q1 2026 in Review
Game Creek Capital reduced its Pfizer (PFE) stake by 0.37% in Q1 2026, selling an estimated $13.3K and leaving 134,375 shares worth $3.77M. The position accounts for 1.25% of the portfolio, ranked #28.
Game Creek Capital first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $16.1M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Game Creek Capital held 134,375 shares of Pfizer worth $3.77M as of Q1 2026.
- Game Creek Capital sold 500 Pfizer shares in Q1 2026, an estimated $13.3K.
- Pfizer made up 1.25% of Game Creek Capital's portfolio in Q1 2026, its #28 holding.
- Game Creek Capital first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
- Game Creek Capital's Pfizer position peaked at $16.1M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Game Creek Capital's 13F filing for Q1 2026, filed 14 May 2026.